Arizona Bioscience News: Arizona Republic partners with Flinn Foundation; Bioscience Roadmap events highlight ecosystem; ASU launches new accelerator

April 5, 2019

By Matt Ellsworth

Innovative storytelling to drive Republic partnership with Flinn Foundation / Arizona Republic

With support from the Flinn Foundation, The Arizona Republic is hiring a multimedia reporter and a digital developer to chronicle Arizona’s bioscience sector, tell the state’s story of innovation in creative ways and deliver those stories to the community through live events and in front of students at all levels.

Insiders say Arizona is making progress in building entrepreneurial ecosystem for bioscience companies / Arizona Daily Star

There was plenty of talk about the recent progress Arizona is making to build an entrepreneurial ecosystem for bioscience companies with some fresh faces leading the charge at the Flinn Foundation’s Arizona’s Bioscience Roadmap annual luncheon in Tucson.

Flagstaff leaders share bioscience progress in annual meeting / Arizona Daily Sun

Nearly 100 of Flagstaff’s leaders in science, education and local government gathered to share recent advancements in the biosciences across northern Arizona and throughout the state at the Flinn Foundation’s annual Arizona’s Bioscience Roadmap Progress Update luncheon.

Tech Launch Arizona showcases Tucson’s brightest minds / KVOA

Tech Launch Arizona, which is dedicated to commercializing the University of Arizona’s inventions stemming from research, honored top inventors and entrepreneurs at its sixth annual I-Squared Awards and Expo event.

ASU launches new startup accelerator for students, alumni / Phoenix Business Journal

Arizona State University and SparkLabs Group, a network of accelerators and venture capital funds, has launched a new startup accelerator program for students and alumni to provide training, mentors and investment funding.

Some Arizona hospitals are struggling in a changing health-care economy / Arizona Republic

Arizona hospitals perform better financially than the national average, but cost pressures, heightened competition, market-share erosion and workforce shortages are squeezing operating margins.

New Type 1 diabetes treatment aims to automatically control blood sugar levels / Daily Wildcat

Professors and researchers at the University of Arizona’s College of Medicine-Tucson have been testing implantable devices that regulate insulin and the possibility of reversing diabetes without the need for immunosuppression.

Click here to sign up to receive Arizona Bioscience News